Red Lighthouse Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
696
+3
+0.4% +$1.44K 0.1% 69
2026
Q1
$341K Buy
+693
New +$376K 0.12% 60
2025
Q4
Sell
-691
Closed -$335K 111
2025
Q3
$335K Buy
691
+1
+0.1% +$465 0.12% 58
2025
Q2
$280K Sell
690
-5
-0.7% -$2.09K 0.11% 60
2025
Q1
$404K Buy
695
+2
+0.3% +$1.08K 0.16% 49
2024
Q4
$361K Sell
693
-2
-0.3% -$1.1K 0.14% 51
2024
Q3
$430K Hold
695
0.17% 50
2024
Q2
$384K Hold
695
0.16% 50
2024
Q1
$404K Buy
695
+1
+0.1% +$561 0.16% 50
2023
Q4
$368K Sell
694
-8
-1% -$3.87K 0.15% 50
2023
Q3
$355K Buy
702
+19
+3% +$10.1K 0.17% 49
2023
Q2
$356K Hold
683
0.16% 47
2023
Q1
$394K Hold
683
0.19% 45
2022
Q4
$376K Buy
+683
New +$362K 0.19% 46

Other funds holding TMO

Red Lighthouse Investment Management's TMO Position: Q2 2026 in Review

Red Lighthouse Investment Management increased its Thermo Fisher Scientific (TMO) stake by 0.43% in Q2 2026, buying an estimated $1.44K and bringing the position to 696 shares worth $349K. The position accounts for 0.1% of the portfolio, ranked #69.

Red Lighthouse Investment Management first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $430K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Red Lighthouse Investment Management held 696 shares of Thermo Fisher Scientific worth $349K as of Q2 2026.
  • Red Lighthouse Investment Management bought 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.1% of Red Lighthouse Investment Management's portfolio in Q2 2026, its #69 holding.
  • Red Lighthouse Investment Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Red Lighthouse Investment Management's Thermo Fisher Scientific position peaked at $430K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Red Lighthouse Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.